Nuclear Medicine Market Analysis North America, Asia, Europe, Rest of World (ROW) - US, Germany, UK, Japan, China - Size and Forecast 2023-2027

Published: Oct 2023 Pages: 169 SKU: IRTNTR75093

Nuclear Medicine Market Analysis Report 2023-2027:

The Global  Nuclear Medicine Market size is estimated to grow by USD 8,057.89 million at a CAGR of 16.48% between 2022 and 2027. 

The global increase in cancer cases has led to a rise in investment in diagnosis and treatment. Cancer is a major cause of mortality, especially in low- and middle-income countries. Predictions show 22 million new cancer cases in the next two decades. Preventable factors include alcohol, tobacco, obesity, and inactivity. The disease's economic impact is substantial due to premature deaths. Developed countries like the US invest heavily in oncology, reducing mortality rates. Developing countries like China and India seek more oncology investment. Nuclear medicines like Americium 241, Californium 252, Cobalt 60, etc., are used for cancer treatment, with demand expected to grow due to increased cancer cases and investments.

Technavio has segmented the market into   Product, Application, and Geography.

  • The product segment is categorized into radiotherapeutics and equipment spect and pet
  • The application segment is fragmented into oncology, cardiology, neurology, and others
  • The geography segment includes key regions such as North America, Asia, Europe, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the Size of the Nuclear Medicine Market During the Forecast Period?

To learn more about this report, Request Free Sample

Nuclear Medicine Market Segmentation by Product, Application, and Geography Analysis

Product Analysis 

The market share growth by the radiotherapeutics segment will be significant during the forecast period. Radiopharmaceuticals are pharmaceuticals drugs having radioactive properties. These are made up of a radioisotope that bonds to an organic molecule. Radiopharmaceutical drugs can be used for therapeutic and diagnostic purposes. These are also used to treat multiple disease sites, such as cancer and cardiac diseases. Such factors will increase segment growth during the forecast period.

Get a glance at the market contribution of various segments View a PDF Sample

The radiotherapeutics segment was valued at USD 1,880.57 million in 2017 and continue to grow by 2021. Radiopharmaceuticals have been known for their therapeutic uses for decades. Nuclear medicine research and development are rapidly growing, introducing new radiopharmaceuticals for treating neuroendocrine, metastatic bone pain, and tumors. The radiopharmaceutical segment is poised for significant growth during the forecast period due to increasing disease prevalence, like cancer and thyroid conditions, driving demand for new treatments.

Application Analysis

The oncology segment dominates the market due to the increasing prevalence of cancer globally. In 2022, about 1.80 million new cancer cases were diagnosed globally. Nuclear medicine, including SPECT and PET equipment, is extensively used for timely cancer diagnosis. The demand for early detection and treatment to reduce mortality rates is driving the adoption of advanced diagnostic imaging methods like SPECT and PET in oncology.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period.

North America dominates the global nuclear medicine market, led by the US and Canada as top revenue generators. Market growth is fueled by changes in healthcare policies and hospital infrastructure, along with trends like hybrid operating rooms and cloud computing. The region's adoption of SPECT scanning systems is accelerated by lower costs and technological advancements. Vendors focus on product launches to offer new and advanced nuclear medicine options. The rise in cancer, neurological disorders, and heart diseases in North America boosts the demand for SPECT scanners. However, the closure of nuclear reactors has caused a shortage of radioisotopes, impacting nuclear medicine production. The US leads the North American market due to significant R&D investments and high cancer prevalence. Key vendors include Bayer, Cardinal Health, and GE Healthcare.

The COVID-19 outbreak had a slightly negative impact on the nuclear medicine market in North America, particularly the US. Lockdowns and restrictions in 2020 and early 2021 led to limited or halted non-urgent treatments and clinical visits, disrupting surgery schedules and lowering sales for nuclear medicine providers. Delays in cardiac and cancer disease procedures hindered market growth. Vendors responded with new strategies like product launches and collaborations. As vaccination drives reduced COVID-19 cases, pharmaceutical industry operations resumed, and the nuclear medicine market is expected to grow in the region due to increasing cancer cases and established vendors.

Buy Now Full Report and Discover More

Key Nuclear Medicine Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Philips- The company offers nuclear medicine such as Spectral Computed Tomography 7500 system.

Bayer AG, Bracco Spa, Cardinal Health Inc., Eckert and Ziegler AG, ECZACIBASI MONROL NUCLEAR PRODUCTS CO., GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Pharmova Ltd., Koninklijke Philips NV, Lantheus Holdings Inc., Mallinckrodt Plc, Medi-Radiopharma , Mirion Technologies Inc., Necsa, Novartis AG, Siemens Healthineers AG, Sirtex Medical Pty Ltd., Telix Pharmaceuticals Ltd., Tema Sinergie SpA, and  TTG Imaging Solutions LLC 

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Nuclear Medicine Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Nuclear Medicine Market Drivers

Increased use of nuclear medicine for detecting diseases at an early stage is a key factor driving the market growth. Nuclear imaging techniques play a crucial role in various medical applications, such as diagnosing central nervous system conditions, treating intracranial tumors and arteriovenous malformations, and aiding in cardiac and breast disease diagnoses. These techniques accurately detect molecular activity, enabling early disease detection and treatment assessment. Therapeutic and diagnostic procedures utilize nuclear medicine for detecting various diseases, particularly heart diseases through SPECT scanning systems and PET scanners. The increasing utilization of nuclear medicine for early disease detection is expected to drive the global nuclear medicine market's growth during the forecast period.

Significant Nuclear Medicine Market Trends

Growing research activities to widen the applications of hybrid imaging is a key trend shaping the market growth. The global nuclear medicine market is poised for growth due to increasing research and development (R&D) efforts to expand hybrid imaging applications. SPECT and PET/CT systems are widely utilized in oncology, particularly in the US, driving R&D activities to broaden hybrid imaging's scope.

Researchers focus on extending the application of dual optical and PET/CT probes to detect atherosclerotic plaque inflammation non-invasively. SPECT hybrid imaging is valuable in identifying individuals at high risk of premature atherosclerosis. Additionally, there is a rise in studies on hybrid systems for treating complex neurological disorders, like using hybrid imaging to understand brain connectivity in neuropsychiatric disorders. Such initiatives are expected to positively impact the global nuclear medicine market during the forecast period.

Major Nuclear Medicine Market Challenges

The high cost of hybrid imaging devices coupled with limited reimbursements is a key challenge hindering the growth of the nuclear medicine market. The high expenses associated with hybrid imaging devices not only impede their adoption but also lead physicians to consider more affordable conventional imaging systems. For example, SPECT gamma cameras cost around USD 0.4 million to USD 0.6 million, and PET/CT scanners are priced at approximately USD 2 million.

The expensive SPECT/CT hybrid imaging systems also face limited adoption, especially in emerging economies. Moreover, the lack of CMS reimbursements further hampers the uptake of SPECT/CT. As a result, physicians may turn to lower-cost standalone systems, with standalone PET/CT scanners ranging from USD 225,000 to USD 750,000. The high cost of PET/CT scanners could further reduce their adoption, adversely affecting the growth of the global nuclear medicine market during the forecast period.

Buy Now Full Report and Discover More

Key Nuclear Medicine Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Nuclear Medicine Market Customer Landscape

Segment Overview

The nuclear medicine market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Product Outlook (USD Million, 2017 - 2027)
    • Radiotherapeutics
    • Equipment SPECT and PET
  • Application Outlook (USD Million, 2017 - 2027)
    • Oncology
    • Cardiology
    • Neurology
    • Others
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Argentina
      • Rest of the world

Nuclear Medicine Market Scope

Report Coverage

Details

Page number

169

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 16.48%

Market growth 2023-2027

USD 8,057.89 million

Market structure

Fragmented

YoY growth 2022-2023(%)

14.03

Regional analysis

North America, Asia, Europe, and Rest of World (ROW)

Performing market contribution

North America at 45%

Key countries

US, Germany, UK, Japan, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Bayer AG, Bracco Spa, Cardinal Health Inc., Eckert and Ziegler AG, ECZACIBASI MONROL NUCLEAR PRODUCTS CO., GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Pharmova Ltd., Koninklijke Philips NV, Lantheus Holdings Inc., Mallinckrodt Plc, Medi-Radiopharma , Mirion Technologies Inc., Necsa, Novartis AG, Siemens Healthineers AG, Sirtex Medical Pty Ltd., Telix Pharmaceuticals Ltd., Tema Sinergie SpA, and  TTG Imaging Solutions LLC 

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Nuclear Medicine Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the Nuclear Medicine Market between 2023 and 2027
  • Precise estimation of the size of the nuclear medicine market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Asia, Europe, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of nuclear medicine market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global nuclear medicine market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global nuclear medicine market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 Application Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Radiotherapeutics - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
    • 6.4 Equipment (SPECT and PET) - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)
      • Exhibit 43: Data Table on Market opportunity by Product ($ million)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 44: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
    • 7.2 Comparison by Application
      • Exhibit 46: Chart on Comparison by Application
      • Exhibit 47: Data Table on Comparison by Application
    • 7.3 Oncology - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Chart on Oncology - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
    • 7.4 Cardiology - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Cardiology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Cardiology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
    • 7.5 Neurology - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
    • 7.6 Others - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.7 Market opportunity by Application
      • Exhibit 64: Market opportunity by Application ($ million)
      • Exhibit 65: Data Table on Market opportunity by Application ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Asia - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Japan - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 Germany - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.11 UK - Market size and forecast 2022-2027
      • Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Bayer AG
              • Exhibit 115: Bayer AG - Overview
              • Exhibit 116: Bayer AG - Business segments
              • Exhibit 117: Bayer AG - Key news
              • Exhibit 118: Bayer AG - Key offerings
              • Exhibit 119: Bayer AG - Segment focus
            • 12.4 Bracco Spa
              • Exhibit 120: Bracco Spa - Overview
              • Exhibit 121: Bracco Spa - Product / Service
              • Exhibit 122: Bracco Spa - Key offerings
            • 12.5 Cardinal Health Inc.
              • Exhibit 123: Cardinal Health Inc. - Overview
              • Exhibit 124: Cardinal Health Inc. - Business segments
              • Exhibit 125: Cardinal Health Inc. - Key news
              • Exhibit 126: Cardinal Health Inc. - Key offerings
              • Exhibit 127: Cardinal Health Inc. - Segment focus
            • 12.6 Eckert and Ziegler AG
              • Exhibit 128: Eckert and Ziegler AG - Overview
              • Exhibit 129: Eckert and Ziegler AG - Business segments
              • Exhibit 130: Eckert and Ziegler AG - Key news
              • Exhibit 131: Eckert and Ziegler AG - Key offerings
              • Exhibit 132: Eckert and Ziegler AG - Segment focus
            • 12.7 ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
              • Exhibit 133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
              • Exhibit 134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
              • Exhibit 135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
            • 12.8 GE Healthcare Technologies Inc.
              • Exhibit 136: GE Healthcare Technologies Inc. - Overview
              • Exhibit 137: GE Healthcare Technologies Inc. - Business segments
              • Exhibit 138: GE Healthcare Technologies Inc. - Key offerings
              • Exhibit 139: GE Healthcare Technologies Inc. - Segment focus
            • 12.9 IBA Radiopharma Solutions
              • Exhibit 140: IBA Radiopharma Solutions - Overview
              • Exhibit 141: IBA Radiopharma Solutions - Business segments
              • Exhibit 142: IBA Radiopharma Solutions - Key offerings
              • Exhibit 143: IBA Radiopharma Solutions - Segment focus
            • 12.10 Jubilant Pharmova Ltd.
              • Exhibit 144: Jubilant Pharmova Ltd. - Overview
              • Exhibit 145: Jubilant Pharmova Ltd. - Business segments
              • Exhibit 146: Jubilant Pharmova Ltd. - Key news
              • Exhibit 147: Jubilant Pharmova Ltd. - Key offerings
              • Exhibit 148: Jubilant Pharmova Ltd. - Segment focus
            • 12.11 Koninklijke Philips NV
              • Exhibit 149: Koninklijke Philips NV - Overview
              • Exhibit 150: Koninklijke Philips NV - Business segments
              • Exhibit 151: Koninklijke Philips NV - Key news
              • Exhibit 152: Koninklijke Philips NV - Key offerings
              • Exhibit 153: Koninklijke Philips NV - Segment focus
            • 12.12 Mallinckrodt Plc
              • Exhibit 154: Mallinckrodt Plc - Overview
              • Exhibit 155: Mallinckrodt Plc - Business segments
              • Exhibit 156: Mallinckrodt Plc - Key news
              • Exhibit 157: Mallinckrodt Plc - Key offerings
              • Exhibit 158: Mallinckrodt Plc - Segment focus
            • 12.13 Medi-Radiopharma
              • Exhibit 159: Medi-Radiopharma - Overview
              • Exhibit 160: Medi-Radiopharma - Product / Service
              • Exhibit 161: Medi-Radiopharma - Key offerings
            • 12.14 Necsa
              • Exhibit 162: Necsa - Overview
              • Exhibit 163: Necsa - Product / Service
              • Exhibit 164: Necsa - Key offerings
            • 12.15 Novartis AG
              • Exhibit 165: Novartis AG - Overview
              • Exhibit 166: Novartis AG - Business segments
              • Exhibit 167: Novartis AG - Key offerings
              • Exhibit 168: Novartis AG - Segment focus
            • 12.16 Siemens Healthineers AG
              • Exhibit 169: Siemens Healthineers AG - Overview
              • Exhibit 170: Siemens Healthineers AG - Business segments
              • Exhibit 171: Siemens Healthineers AG - Key news
              • Exhibit 172: Siemens Healthineers AG - Key offerings
              • Exhibit 173: Siemens Healthineers AG - Segment focus
            • 12.17 Sirtex Medical Pty Ltd.
              • Exhibit 174: Sirtex Medical Pty Ltd. - Overview
              • Exhibit 175: Sirtex Medical Pty Ltd. - Product / Service
              • Exhibit 176: Sirtex Medical Pty Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 177: Inclusions checklist
                • Exhibit 178: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 179: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 180: Research methodology
                • Exhibit 181: Validation techniques employed for market sizing
                • Exhibit 182: Information sources
              • 13.5 List of abbreviations
                • Exhibit 183: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              nuclear medicine market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis